| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c3c9fc3cb0028234aedb8df651f9d2e4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-2462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y302-01017 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-36 |
| filingDate |
2001-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aafa2af3d7c1c7a2bfd43d0aa5331ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6783550345bf2ed53cb49eacc7f11fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdebbddc7dd00c9edea1a862dc7c3f88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd8ba650190a235ad138cb9c593094e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b5a7429645b84ee4e4a6ec7a03cbb44 |
| publicationDate |
2006-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7125550-B2 |
| titleOfInvention |
Human sperm specific lysozyme-like proteins |
| abstract |
The present invention relates to two novel, testis-specific proteins (C19 and C23) that arc lysozyme paralogues. The proteins are believed to play a role in capacitation of sperm and the fertilization of the ovum. Therefore these compounds make ideal targets for the design of contraceptive agents. The C19 and C23 proteins can also be modified to establish lysozyme activity and the modified proteins can then be used in all applications that currently exist for lysozymes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020061560-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010183617-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3666285-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109295088-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9803012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009214552-A1 |
| priorityDate |
2000-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |